Clinical Trial Update: Drug Interaction Study of SAR302503 in Patients With Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 drug interaction study of SAR302503 in patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SAR302503

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED